Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer

Epidermal growth factor receptor (EGFR) is extensively expressed in head and neck cancer. However, EGFR-targeted therapy has only modest efficacy in head and neck cancer, through mechanisms that are not fully understood. Here, we found that inhibition of EGFR by erlotinib stimulated phosphorylation...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Li, Rui, You, Shuo, Hu, Zhongliang, Chen, Zhuo G., Sica, Gabriel L., Khuri, Fadlo R., Curran, Walter J., Shin, Dong M., Deng, Xingming
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2013
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3760825/
https://ncbi.nlm.nih.gov/pubmed/24019973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0074670
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares